[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 163,532
  • Shares Outstanding, K 69,588
  • Annual Sales, $ 149,160 K
  • Annual Income, $ -39,000 K
  • EBIT $ -29 M
  • EBITDA $ -26 M
  • 60-Month Beta 1.03
  • Price/Sales 1.07
  • Price/Cash Flow N/A
  • Price/Book 8.81

Options Overview Details

View History
  • Implied Volatility 156.07% (-16.31%)
  • Historical Volatility 96.89%
  • IV Percentile 17%
  • IV Rank 8.77%
  • IV High 728.52% on 03/13/26
  • IV Low 101.04% on 08/20/25
  • Expected Move (DTE 15) 0.26 (11.18%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 596
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 8,430
  • Open Int (30-Day) 7,088
  • Expected Range 2.03 to 2.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.11
  • Number of Estimates 1
  • High Estimate $-0.11
  • Low Estimate $-0.11
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) +26.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.44 +59.38%
on 07/07/26
2.43 -5.56%
on 08/05/26
+0.74 (+47.12%)
since 07/06/26
3-Month
1.12 +105.83%
on 05/19/26
2.43 -5.56%
on 08/05/26
+0.39 (+20.16%)
since 05/06/26
52-Week
0.80 +186.88%
on 03/17/26
4.42 -48.08%
on 08/07/25
-1.95 (-45.94%)
since 08/06/25

Most Recent Stories

More News
Neuronetics and Jorey Chernett Announce Shared Vision

Chernett Affirms Comfort with the Company’s Capital Position and Confidence in Management’s Execution Establishes Path Towards Neuronetics Board Representation MALVERN, Pa., Aug. 03, 2026...

STIM : 2.31 (-1.70%)
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through...

STIM : 2.31 (-1.70%)
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar ® TMS technology with direct patient care through...

STIM : 2.31 (-1.70%)
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through...

STIM : 2.31 (-1.70%)
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience Cory Anderson promoted to Executive Vice President and General Manager,...

AXGN : 45.16 (-0.13%)
STIM : 2.31 (-1.70%)
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026

MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through...

STIM : 2.31 (-1.70%)
Neuronetics Appoints Robert Greene as Senior Vice President Sales

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life...

STIM : 2.31 (-1.70%)
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life...

STIM : 2.31 (-1.70%)
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life...

STIM : 2.31 (-1.70%)
Neuronetics: Q1 Earnings Snapshot

Neuronetics: Q1 Earnings Snapshot

STIM : 2.31 (-1.70%)

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 2.66
2nd Resistance Point 2.55
1st Resistance Point 2.45
Last Price 2.31
1st Support Level 2.23
2nd Support Level 2.12
3rd Support Level 2.02

See More

52-Week High 4.42
Fibonacci 61.8% 3.04
Fibonacci 50% 2.61
Last Price 2.31
Fibonacci 38.2% 2.18
52-Week Low 0.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.